Session » Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

10:30AM-12:30PM

Abstract Number: 2132

A Quality Improvement Initiative to Increase Osteoporosis Screening in Internal Medicine Resident Led Primary Care Clinics

10:30AM-12:30PM

Abstract Number: 2143

Analysis of Effectiveness and Safety of Romosozumab in Patients with Very High Risk of Fracture in a Spanish Population

10:30AM-12:30PM

Abstract Number: 2126

Analysis of the Evolution of Bone Mineral Density in the Spanish Population: Results of the OsteoSER Study

10:30AM-12:30PM

Abstract Number: 2116

Artificial Intelligence Classifier for Osteoporosis Detection from Chest Radiographs: Performance Evaluation and Literature Comparison with Quantitative Ultrasound

10:30AM-12:30PM

Abstract Number: 2115

Clinical Impact of Acute Symptomatic Vertebral Fractures in the United States: An Observational Study

10:30AM-12:30PM

Abstract Number: 2142

Comparison of Bone Mineral Density at the Distal Radius, Hip, and Lumbar Spine in Female Patients Undergoing Surgery for Proximal Femur or Distal Radius Fractures: Implications for Osteoporosis Diagnosis

10:30AM-12:30PM

Abstract Number: 2114

CT and DXA Bone Fragility Evaluation After Bariatric Surgery

10:30AM-12:30PM

Abstract Number: 2118

Cytotoxic T Lymphocyte Antigen-4 Improves Osteoporosis in Patient with Rheumatoid Arthritis

10:30AM-12:30PM

Abstract Number: 2135

Disability, Functional Limitation, and Use of Anti-fracture Drug Therapies in a Cohort of 3651 U.S. Adults with Osteogenesis Imperfecta

10:30AM-12:30PM

Abstract Number: 2112

Discontinuation and Non-Publication of Osteoporosis Studies: An Observational Analysis of 7,670,624 Patients

10:30AM-12:30PM

Abstract Number: 2113

Discontinuation and Non-publication of Postmenopausal Osteoporosis Clinical Studies: A Cross-sectional Analysis of 345,435 Patients

10:30AM-12:30PM

Abstract Number: 2136

Distal Radius Correlation with Femur and Lumbar Spine T-scores: A Comprehensive Analysis

10:30AM-12:30PM

Abstract Number: 2138

DXA-derived 3D Parameters of the Hip Discriminate Prevalent Fragility Fractures in Individuals with Axial Spondyloarthritis

10:30AM-12:30PM

Abstract Number: 2123

Epidemiology of Bone Health and Fracture in Gout Patients

10:30AM-12:30PM

Abstract Number: 2120

EvaluationofBone Mineral Densityand Trabecular Bone Score in JuvenileSystemicLupusErythematosusPatientsUsing Dual-Energy X-rayAbsorptiometry

10:30AM-12:30PM

Abstract Number: 2129

Fracture Risk Assessment Tool (FRAX®) Scores Predict Mortality in Community-Dwelling Elderlies

10:30AM-12:30PM

Abstract Number: 2137

Fractures Post Lung Transplant: A Retrospective Cohort Study Conducted at an International Transplant Center

10:30AM-12:30PM

Abstract Number: 2140

Frailty Is Associated with Lower Bone Mineral Density in US Veterans with Rheumatoid Arthritis

10:30AM-12:30PM

Abstract Number: 2139

Generation of a Human 3D Bone Model to Mimic Glucocorticoid- induced Osteoporosis In Vitro

10:30AM-12:30PM

Abstract Number: 2141

Glucocorticoid Therapy-Associated Bone Fractures Are Associated with Osteoporosis Underscreening in Patients with Rheumatoid Arthritis

10:30AM-12:30PM

Abstract Number: 2119

IL-17 Blockade Therapy Improves Symptoms in Patients with Active Axial Spondyloarthritis Without Occurrence of New Vertebral Fractures

10:30AM-12:30PM

Abstract Number: 2148

Impact of Hip Fractures in the Elderly Population: Functional Status, Readmission, and One-Year Mortality

10:30AM-12:30PM

Abstract Number: 2144

Impact of Immunogenicity on Clinical Outcomes in Postmenopausal Women with Osteoporosis: Results from a Randomized Controlled Phase 3 Study to Compare CT-P41 (Proposed Denosumab Biosimilar) and Reference Denosumab

10:30AM-12:30PM

Abstract Number: 2121

Increased Fracture Rates in Patients Continuing Methotrexate After Methotrexate-associated Lower Limb Insufficiency Fractures: A Retrospective Follow-up Study

10:30AM-12:30PM

Abstract Number: 2134

PEX5 Acts as a Negative Regulator of RANKL-induced Osteoclastogenesis In Vitro and Inflammatory Calvarial Bone Destruction In Vivo

10:30AM-12:30PM

Abstract Number: 2130

Post-fracture Survival for Rheumatoid Arthritis Patients Is Not Improving

10:30AM-12:30PM

Abstract Number: 2147

Primary and Secondary Prevention of Osteoporotic Fracture in the Elderly Patients

10:30AM-12:30PM

Abstract Number: 2127

Relationship Between Serum Uric Acid and Trabecular Bone Score (TBS) in Healthy Population

10:30AM-12:30PM

Abstract Number: 2122

Rheum for Improvement: Screening and Treatment of Glucocorticoid Induced Osteoporosis

10:30AM-12:30PM

Abstract Number: 2131

Role of LECT2 in the Regulation of Bone Metabolism In Vitro and In Vivo

10:30AM-12:30PM

Abstract Number: 2125

Strengthening Fracture Risk Prediction in Rheumatoid Arthritis: Integrating a Self-report Sarcopenia Screening Tool (SARC-F) and Fracture Risk Assessment Tool (FRAX) Scores

10:30AM-12:30PM

Abstract Number: 2145

Study of Bone Metabolism in Patients Diagnosed with Osteogenesis Imperfecta.

10:30AM-12:30PM

Abstract Number: 2117

The Risk of Medication-related Osteonecrosis of the Jaw (MRONJ) in a Patient with Osteoporosis Treated with Antiresorptive Therapy and Undergoing Dental Care Is Negligible with a CTX Threshold Above 260

10:30AM-12:30PM

Abstract Number: 2128

Trabecular Bone Score Curve from a Qatari Population, Data from Qatar Biobank

10:30AM-12:30PM

Abstract Number: 2133

Unveiling the Association Between Low-Density Lipoprotein Cholesterol Lowering and Fracture Risk Among Patients with Hyperlipidaemia in a Population-Based Cohort Study: The Lower, the Better

10:30AM-12:30PM

Abstract Number: 2146

Validation of the Simple Calculated Osteoporosis Risk Estimation and Osteoporosis Self-assessment Tool Among People Aging with HIV in Peru

10:30AM-12:30PM

Abstract Number: 2124

WITHDRAWN